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1 Introduction 
The aim of this thesis was to investigate whether the Saccharomyces cerevisiae sporu-
lation specific protein 20 could be used to anchor hyaluronic acid pathway enzymes to 
the plasma membrane of Pichia pastoris, essentially creating a substrate channel for 
more efficient hyaluronic acid production. Hyaluronic acid pathway enzymes are native-
ly scattered in the cytosol; therefore, many of the precursors needed to produce high 
quality hyaluronic acid are depleted before the transmembrane protein hyaluronan syn-
thase can turn them into HA. This inefficient precursor utilisation leads to lower molecu-
lar weight and lower production titers of hyaluronic acid in recombinant production 
hosts. 
Hyaluronic acid is an interesting molecule due to its versatile physical and biochemical 
properties as well as high immunocompatibility. Due to these properties, hyaluronic 
acid has already been used in numerous medical, cosmetic and pharmaceutical appli-
cations. The market value of hyaluronic acid was estimated to be 5.32 billion USD in 
2012 and is expected to grow up to 9.85 billion USD by 2019 (De Oliveria et.al., 2016). 
This thesis was made for VTT’s production host engineering research team as part of 
the Academy of Finland funded SynBioPol project. VTT’s production host engineering 
team provides novel genetic tools accompanied by bioinformatics to efficiently engineer 
microbes for the production of useful chemicals and biofuels. VTT Technical Research 
Centre of Finland Ltd is a research and technology company that provides technical 
and innovative solutions for both the private and the public sector.  
This thesis will first discuss the general information about hyaluronic acid and the 
mechanism behind its production, SNARE proteins, sporulation specific protein 20, 
briefly discuss fluorescent proteins and their application in live cell imaging and the 
genetic engineering tools for Pichia pastoris. Then, it will move on to highlight the used 
materials, molecular biology and microbiology methods used in this thesis, to and con-
clude with the results and the discussion. 
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1.1 Hyaluronic acid  
Hyaluronic acid (HA) (Figure 1) is a linear and rigid biopolymer that belongs to the 
class of glycosaminoglycans. HA consists of repeating units of disaccharides glucuron-
ic acid (GlcA) and N-actylglycosamine (GlcNAc) linked by β1,3- and β1,4-glycosidic 
bonds. HA is produced by an transmembrane enzyme called hyaluronan synthase 
(HAS) that can be found from the plasma membrane of mammal, amphibian and bacte-
rial cells. HA is present in all human organs, and it is highly abundant in connective 
tissues such as cartilage tissue and responsible for the maintenance of tissue homeo-
stasis (De Oliveria et.al., 2016). HA is also directly involved in several other processes 
like embryogenesis, inflammation, metastasis, angiogenesis and wound healing. HA is 
also responsible for the smooth appearance of skin and with aging HA production de-
creases which results in wrinkles (De Oliveria et.al., 2016).  
 
 Structure of HA showing the β-1,3 and β-1,4 glycosidic bonds and the precursors 
glucuronic acid and N-actylglycosamine  (De Oliveria et.al., 2016) 
1.1.1 Production of HA 
Traditionally HA has been extracted chemically from animal tissues like rooster combs, 
bovine eyes and umbilical cords. This approach has many disadvantages and it can 
lead to degradation of HA, due to endogenous hyaluronidase enzyme activity and 
harsh extraction conditions. This method also has high purification cost due to con-
cerns over infectious zoonotic disease and allergic reactions. Today HA is produced 
mainly through microbial fermentation although this method produces lower molecular 
weight (MW) HA than what can be obtained from animal tissues (De Oliveria et.al., 
2016; Joeng et.al., 2014). 
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Most naturally occurring microbes that produce HA are pathogenic bacteria such as 
Pasteurella multocida and gram-positive Streptococcus group A and C. Some eukary-
otes like the yeast Cryptococcus neoformans or an algae Chlorella.sp can produce HA 
natively although in the latter case this only happens when Chorella.sp is infected with 
the Paramecium bursaria chlorella virus (De Oliveria et.al., 2016). The first wild type 
microbe used in industrial HA production was Streptococcus zooepidemicus in the ear-
ly 1980s. Although Streptococcus zooepidemicus can produce a high molecular weight 
HA, it also produces potentially toxic and pathogenic side products that need to be puri-
fied, raising the purification cost (De Oliveria et.al., 2016). Higher purification cost as-
sociated with pathogenic bacteria fermentations has led to the development of several 
recombinant generally regarded as safe (GRAS) organisms that can produce high 
yields of HA, with sufficient MW for some medical applications (De Oliveria et.al., 2016; 
Joeng et.al., 2014). Most recombinant host producing HA are GRAS bacteria that have 
already been used in industrial application for years. These include bacteria such as, 
Lactococcus lactis, Corybacterium glutamicum and Bacillus subtilis. Only a few eukar-
yotic organisms have been genetically engineered to produce HA. These eukaryotes 
include yeasts like Saccharomyces cerevisiae, Pichia pastoris and plant cell cultures of 
Nicotiana benthamiana (De Oliveria et.al., 2016; Joeng et.al., 2014). 
1.1.2 HA metabolism 
The HA metabolic pathway originates from the glycolytic pathway. The precursors for 
HA are synthesized from deviations of glucose-6-phospate and fructose-6-phosphate 
by multiple enzymes inside the cytoplasm (Figure 2) (De Oliveria et.al., 2016). The 
production of HA by the HAS enzyme competes for the HA pathway precursor with 
other cellular mechanisms like cell wall polysaccharide synthesis, teichoic acid and 
peptidoglycan synthesise as well as glycolysis (De Oliveria et.al., 2016). This competi-
tion between these often essential cellular mechanisms, can greatly reduce the availa-
bility of precursors for the HAS enzyme and therefore lead to reduction in HA produc-
tion and molecular weight (MW) (De Oliveria et.al., 2016). Most of these enzymes are 
coded by the production hosts native genes that are called hasC, hasB and hasE in 
this thesis. Since many industrial yeast strains cannot produce the HAS enzyme on 
their own and genes from other eukaryotes must be transformed into these yeasts in 
ordered for them to produce HA. These recombinant genes are called xhasA2 and 
xhasB in this thesis, and they are genes from Xenopus laevis (Joeng et.al., 2014).  
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 HA pathway in a recombinant Pichia pastoris. XhasA2 and xhasB genes coding the 
HAS enzyme and UPD-glucose dehydrogenase are transformed from Xenopus laevis since 
Pichia pastoris does not produce the HAS enzyme natively (Joeng E et.al., 2014). 
The HAS enzyme (xhasA2) is a transmembrane protein that catalyses the polymerisa-
tion of UDP-GlcA and UDP-GlcNAc intracellularly to form HA that is then secreted to 
extracellular matrix. The HAS enzyme is a multidomain enzyme that contains various 
binding sites (De Oliveria et.al., 2016) (Figure 3): 
 (1 – 2) UDP-GlcA- and UDP-GlcNAc- binding sites that capture the pre-
cursors 
 (3 – 4) UDP-GlcNAc β1,4-  and UPD-GlcA β1,3-transferase domains that 
bind the precursors together 
 (5 – 6) HA acceptor site that receives the polymer and the excretion site 
that excretes the polymer out of the cell. 
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 Proposed structure of the HAS enzyme and its various binding domains (Weigel, 
2004) 
1.1.3 Applications of HA 
HA with sufficient MW of more than 2 MDa has a multitude of industrial and medical 
uses, due to its versatile physiochemical properties such as high hygroscopicity, visco-
elasticity, high biocompatibility, non-immunogenicity and non-toxic degradation prod-
ucts (De Oliveria et.al., 2016; Kogan et.al., 2007). The properties of HA are highly de-
pendent on its MW and HA molecules with small MW often have opposing biological 
function compared to its high molecular weight counterparts (De Oliveria et.al., 2016; 
Kogan et.al., 2007). The medical industry has a wide range of surgical uses for HA 
(Kogan et.al., 2007) and these aplications include: 
 Viscosurgery where HA is used to protect and provide space between 
delicate tissues during ophtmalogical surgeries 
 Viscoaugmentation where HA is used to fill and augment tissue spaces 
such as skin, muscles and vocal tissues 
 Viscoseparation where HA is used to separate injured or traumatized 
connective tissue to prevent excessive scaring and adhesion 
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 Viscosupplementation where HA is used to replace or supplement of tis-
sue fluids 
 Viscoprotection where HA acts as a barrier for injured tissues protecting 
them from dryness, environmental agents and it promotes wound healing  
The cosmetic industry also has a variety of uses for HA, and it can be found in many 
over the counter beauty products, boasting claims such as:  
“Proven anti-aging skincare properties fill-in and diminish the look of fine lines 
and wrinkles. See a noticeable difference with visibly plumper, softer and 
smoother skin with this anti-aging hyaluronic acid serum (Amazon, 2017) “ 
Unfortunately claims such as these are false because HA cannot penetrate the skin 
due to its high molecular weight (Boss and Meinardi, 2000), but HA can be used as 
dermal filler if it is injected directly under the skin, for example, to smoothen wrinkles 
(Kogan et.al., 2007). The drug industry has used HA for drug delivery, and it has been 
used to make microcapsules and microspheres to deliver compounds, such as plas-
mids and monoclonal antibodies (Kogan et.al., 2007). 
1.2 SNARE proteins as membrane anchors 
Soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptors 
(SNARE proteins) are responsible for vesicle fusion to the plasma membrane and other 
intracellular membranes. SNAREs can be divided into two groups; v-SNAREs that pri-
marily reside in vesicles and mediate vesicle fusion and t-SNAREs that reside on 
plasma- and other membranes (Liu S et.al., 2007). Three examples of distinct SNARE 
proteins can be found in the neuronal SNARE complex where they mediate vesicle 
fusion to the presynaptic membrane (Dunman and Forte, 2003). These proteins are 
called VAMP (vesicle associated membrane protein), SNAP-25 (synaptosome-
associated protein) and syntaxin 1A.  VAMP (sometimes referred to as synaptobrevin) 
is a single pass transmembrane protein that can be considered as a v-SNARE since it 
is localized to vesicle membranes. SNAP-25 on the other hand is regarded as a t-
SNARE protein and it has two SNARE domains which associate it to the plasma mem-
brane. Also, considers as a t-SNARE protein, syntaxin 1A binds to the plasma mem-
brane with only one transmembrane domain (Dunman and Forte, 2003). 
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The prevailing theory how the aforementioned proteins form the SNARE complex and 
mediate membrane fusion is called zippering, although this so-called SNARE hypothe-
sis is still debated (Chen Yu et.al., 2001). The SNARE hypothesis suggests that the 
SNARE proteins bind together in such a way, that v-SNARE starts to coil around the t-
SNARE proteins N-terminus towards the C-terminus, pulling the vesicle and the plasma 
membrane closer to each other and at the same time providing the necessary lateral 
tension to fuse the membranes together as seen in Figure 4 (Liu et.al., 2007; Dunman 
and Forte, 2003; Chen Yu et.al., 2001).  
 
 Proposed model of the SNARE hypothesis. A: SNARE proteins not yet connected. B: 
SNARE complex starts zippering from N-terminus towards C-terminus. C: Further zippering 
causes lateral tension and exposes bilayer interior. D: Void space in the membrane junction 
causes the layers to fuse. E: Lateral tension in the bilayer contact area causes membrane 
breakdown, forming a fusion pore. F: Fusion pore expands and membrane relaxes (Chen 
Yu A, 2001). 
All the aforementioned SNARE proteins have similar homologs in other eukaryotic or-
ganisms like yeasts. 
1.3 Saccharomyces cerevisiae sporulation specific protein 20 (Spo20) 
Spo20 is a SNAP25 family protein, and, in Saccharomyces cerevisiae, it is an essential 
factor in vesicle fusion into the forespore membrane. Spo20 is also critical to the for-
mation of the forespore membrane and spo20+ gene deficient yeasts are not capable of 
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forming spores or viable cells (Nakase et.al., 2001; Nakanishi et.al. 2004; Neiman 
et.al., 2000) Spo20 translocates to the forespore membrane on the completion, of mei-
osis and, has been reported to localize to the nucleus when cells are nitrogen starved, 
furthermore this nucleus localization persist through out conjugation and meiosis (Nak-
ase et.al., 2001; Nakanishi et.al., 2004; Neiman et.al., 2000) 
In a 2000 study by Neiman, et al (Neiman et.al., 2000) provided proof for a regulatory 
N-terminal region in Spo20 that is required for successful function of the protein during 
sporulation. A later 2004 study by Nakanishi, et al (Nakanishi et.al., 2004), suggests 
that Spo20 has an amphipathic helix close to its N-terminal that binds to acidic phos-
pholipids and the most likely ligand for this helix is phosphatidic acid (Nakanishi et.al., 
2004). Since the discovery of this amphipathic region of the Spo20, many studies have 
used this region as a phosphatidic acid biosensor for numerous applications (Liu et.al., 
2007; Ferraz-Nogueira et.al, 2014; Horchani et.al, 2014). A 2014 study by Horachin et 
al (Horchani et.al, 2014), suggested that the amphipathic helix does not bind specifical-
ly to phosphatidic acid alone, but rather it has non-specific interactions with mem-
branes containing anionic lipids. 
Due to its ability to bind to many of the yeast cells membranes that contain anionic li-
pids, the amphipathic region of the Spo20 seems a suitable candidate to investigate 
whether or not it can be used as a part of a chimera protein to anchor the HA pathway 
enzymes to cell membranes. This membrane anchoring would bring all the necessary 
enzymes and precursors closer to the HAS enzyme that is already bound to the plasma 
membrane, essentially creating a more efficient substrate channel and therefore raising 
MW and production titers. 
1.4 Fluorescent proteins and their applications in live cell imaging 
The Fluorescent proteins (FP) are proteins, which fluoresces when excited with UV-
light. Excitation of the chromophores electrons forces them to jump to a higher orbital 
and when these electrons decay back to their original orbitals, the released energy is 
emitted as light, in wavelength unique to that chromophore. The light emitted can be 
detected by photo sensors and this technique is used, for example, in immunofluores-
cence assays. 
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Fluorescent proteins are highly conserved in size and all the green fluorescent protein 
family proteins (GFP) whether they are genetically manipulated or from different spe-
cies, are 25 KDa in size (Kremers et.al., 2011). All FPs also share highly conserved 
amino acids and without them the central chromophore does not form. Some of the 
examples of these conserved amino acids are glycines 20/33/67/191, tyrosine 66 and 
phenylalanine 130 (Kremers J et.al., 2011). FPs and GFPs form a barrel like molecule 
from eleven β-sheets that surround the central α-helix. This protein structure protects 
the α-helix and the chromophore attached to it from solvents, thus the molecule is very 
stable (Chudakov et.al., 2010, p1105; Kremers et.al., 2011). Although all FPs have 
many conserved amino acids, the rest of the amino acid chain can be modified to pro-
duce a plethora of FPs with different emission colours and physical properties (Kermes 
et.al., 2011) 
FPs can be used in numerous applications ranging from DNA, RNA, protein, cell and 
tissue labelling to promoter tracking and studying protein-protein interactions (Chuda-
kov et.al., 2010, p1129-1137). In this thesis FPs are used as protein labels to track the 
localization of the HA metabolic pathways enzyme Spo20 chimera protein in the cell.  
1.5 Recombinant protein production in Pichia pastoris 
Pichia pastoris is a methylotrophic yeast that can use methanol as its sole carbon 
source. It has two strong methanol inducible alcohol oxidase promotors AOX1 and 
AOX2 that are repressed by glucose. The Philips Petroleum Company developed the 
first Pichia pastoris expression system in the 1980s (Gregg, 2017) and the recent re-
lease of their expression system has led to a wealth of genetic information, and ex-
pression vectors for Pichia pastoris are readily available from Invitrogen. Pichia pastor-
is like Saccharomyces cerevisiae is considered a model organism and the whole ge-
nome of Pichia pastoris was sequenced in 2009 (De Schutter et.al., 2009).  
A typical genetic engineering workflow begins with the selection of an expression sys-
tem in other words the host organism. After the host organism has been chosen, the 
amplification of the gene or the genes of interest with PCR follows. This of course re-
quires enough sequence information about the genes that the right kind of PCR pri-
mers can be designed. After the genes of interest have been isolated, they can be in-
serted into the vector. This happens by identifying the right restriction sites in the vector 
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that correspond to the inserts restriction sites and choosing the restriction enzymes 
accordingly.  
Inserts are usually designed so that they attach to a core promoter that regulates the 
expression of the insert. In Pichia pastoris the usual core promotors are the AOX1 and 
AOX2 promotors or the constitutive glyceraldehyde-3-phosphate dehydrogenase pro-
motor also known as the GAP promotor (Li et.al., 2007). When the vector has been 
assembled, it is transformed by electroporation or chemical transformation into E.coli 
for cloning, then purified and digested with restriction enzymes to see if the vector was 
assembled correctly or possibly sequenced, to make sure the insert is in the correct 
frame and that there are no minor assembly errors that are non-detectable by diges-
tions. Correct vectors are then linearized with a restriction enzyme and transformed 
usually by lithium acetate transformation or by electroporation into yeast cells. In the 
case of Pichia pastoris electroporation is the preferred transformation method (Çelikr 
et.al., 2011; Li et.al., 2007). Transformed colonies can then be identified by a selective 
marker that is usually an antibiotic resistance gene or an auxotrophic marker such as 
LEU3 that is a transcriptional regulator of leucine metabolism. Auxotrophic markers are 
genes that inactivate the organisms´ ability to produce an organic compound that is 
essential to its growth. Therefore, auxotrophic organisms cannot grow on media that 
does not have this essential compound added. 
1.6 Vector design  
Many Pichia pastoris expression vectors share an expression cassette that is com-
posed of an inducible or constitutive promotor (usually AOX1), a transcriptional termi-
nator (usually AOX1 terminator) that has a polyadenylation site, and a multiple cloning 
site in between the promotor and terminator for the insertion of recombinant gene. 
These features ensure that the mRNA is familiar to the yeasts cellular machinery and 
therefore it does not affect the stability or translational efficiency of the mRNA (Li et.al., 
2007). Vectors might also have multiple reporter genes such as FP tags that can be 
fused to the N- or C-terminal of the recombinant protein. For example, in the pGAPZ-
plasmid (Figure 5) these protein tags are coded by the c-myc epitope and the 6xHis 
tag. The c-myc epitope tag can be used as an antibody tag if there are no antibodies 
for the protein that is being expressed from the vector, it can also be used to purify the 
protein by affinity chromatography. The 6xHistadine tag can be used to purify the ex-
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pressed proteins by affinity chromatography (Life Technologies Corporation, 2010). A 
vector plasmid also includes multiple other variable features such as an E.coli origin of 
replication for the maintenance of vector plasmids in E.coli glycerol stocks, multiple 
cloning site, terminators and promotors that drive the selection marker expression as 
well as a the selective marker for both E.coli and Pichia pastoris.  
 
 pGAPZ plasmid map. pGAPZ includes three different constitutive promotors; GAP 
promotor for gene insert expression, TEF1 for Zeocin resistance in Pichia.p and EM7 for 
Zeocin resistance in E.coli. The plasmid also includes two terminators AOX1 terminator for 
the gene insert and CYC1 terminator of Zeocin resistance. Other notable features are the 
pUC E.coli origin of replication, multiple cloning site and two protein tags c-myc epitope and 
6xhis tag (Life Technologies Corporation, 2010). 
Using the features in the pGAPZ plasmid a chimera protein can be created. In this the-
sis the chimera proteins are comprised of the FP tag coded to one of the terminals of 
the HA metabolic enzyme, one of the metabolic pathway enzymes and finally the am-
phipathic region of the Spo20 coded to the opposite terminal of the metabolic pathway 
enzyme. pGAPZ can also be used as an integration vector to Pichia pastoris. This is 
possible by linearizing the plasmid at the GAP promotor after which it can be integrated 
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to the GAP locus by homologous recombination (Life Technologies Corporation, 2010, 
p3).  
1.7 Vector construction 
The expression cassettes can be built in the following fashion. First the Spo20 amphi-
pathic region needs to be amplified from the gDNA of Saccharomyces cerevisiae with 
PCR. This can be accomplished by creating a forward primer with one the following 
restriction sites: EcoR-I, Pml-I or Sfl-I. The reverse primer should include a Xho-I re-
striction site so the Spo20 gene can be ligated in frame with the metabolic enzyme 
gene. A GFP gene can be ligated in frame with the metabolic enzyme gene using pri-
mers with Xba-I sites designed into them. Examples of these primers can be found 
from Table 6. 
 Examples of primers to amplify and add restriction sites to the Spo20 amphi-
pathic region and a GFP. Primers generated with Geneious 8.1.9 
Gene 
PCR 
prod-
uct size 
Primer direction 
and restriction 
site 
Sequence TM °C 
GFP 729 bp 
Forward, Eco-RI GAATTCATGAGTAAAGGAGAAGAACT 50.7 
Reverse, Xho-I CTCGAGTTATTTGTATAGTTCATCCATG 49.4 
Spo20 134 bp 
Forward, Xba-I TCTAGAATGGATAATT-GTTCTGGCTCGA 57.6 
Reverse, Xba-I TCTAGAGCTGGTTTTTGTCGCACATC 58.6 
This approach produces a chimera protein with the Spo20 amphipathic region coded to 
the C-terminal of the protein and a GFP coded to the N-terminal. The order can be re-
versed by designing the PCR primers with Xba-I and EcoR-I for the GFP gene and 
Xho-I sites for the Spo20 gene. Once a cloning vector containing the combinations of a 
FP, a metabolic enzyme (xhasA2 for example) and the Spo20 helix has been assem-
bled into the pGAPZB plasmid, it can be transformed into E.coli. These transformants 
can be screened with colony PCR for the correctly assembled plasmids. Once these 
plasmids have been isolated a restriction analysis can be performed to screen the cor-
rectly assembled plasmids. These plasmids can then be sequenced and the construc-
tion of the expression cassette can begin. 
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The expression cassettes can be built in the same vector (pGAPZB) using the Bgl-II 
and Bam-HI restriction sites. One of the vectors can be linearized with Bam-HI and 
another vector can be digested with both Bam-HI and Bgl-II After the digestion the vec-
tors can be ligated with T4-ligase to form a vector with the pGAPZB backbone, followed 
by the pGAP promotor, Spo20 helix-xhasA2-FP, AOXI terminator, pGAP promotor, 
Spo20 helix-xhasB-FP, AOXI terminator (Figure 6). This vector can then be linearized 
again with Bam-HI and another vector digested by Bam-HI and Bgl-II can be ligated 
into that vector. This would create an expression cassette with the genes Spo20 helix-
xhasA2-FP, Spo20 helix-xhasB-FP, Spo20 helix-hasC-FP etc. (Figure 6). This process 
can be repeated until an expression cassette with all the chimera proteins coded into it 
is created 
 
 Construction process of the chimera protein expression cassette. 
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The resulting expression cassette (Figure 7) can then be transformed into E.coli, 
screened with colony PCR, restriction analysis and finally sequenced. Once the right 
expression vector is found, it can be transformed into Pichia pastoris. 
 
 Complete expression cassette including all the necessary recombinant genes. 
The transformed colonies can be screened with colony PCR, sequenced and finally 
imaged with fluorescent microscopy to verify the localization of each metabolic en-
zyme. Finally, the expression of the genes can be measured with qPCR. 
2 Materials and methods 
The genetic engineering of Pichia pastoris GS115 (Invitrogen) was started with the 
amplification of the genes xhasA2, xhasB, hasC, hasD and hasE by KAPA Hifi PCR 
(Kapa Biosystems). After the successful isolation of the genes they and the pGAPZB 
plasmid (Invitrogen) were digested with Xho-I and Xba-I. After the digestions, the 
genes were inserted into pGAPZB using T4 ligase (New England Biolabs) and then 
cloned into a TOP10 E.coli strain. Cloned E.coli were screened with colony PCR using 
DyNAzyme II (Thermo Fisher) and the potentially correct plasmids were extracted us-
ing GeneJET miniprep (Thermo Fisher) column extraction, and then digested with Xho-
I and Xba-I. Digested constructs were screened with agarose gel electrophoresis and 
sent to Seqlab Sequence Laboratories GmbH (Germany) for sequencing. After se-
quencing, the correct constructs were linearized using Bgl-II and then transformed to 
Pichia pastoris using electroporation. Transformed Pichia pastoris colonies were 
screened with DyNAzyme II colony PCR. 
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2.1 Phenol/chloroform purification of Pichia pastoris genomic DNA (gDNA)  
Purification of Pichia pastoris GS115 gDNA was done with phenol/chloroform purifica-
tion as follows. A 10 mL overnight culture of GS115 was grown in YPD medium in a 
250 rpm shaker at 30°C and the cells were collected next morning by centrifuging 5 
minutes at 3000 rpm. Supernatant was decanted off and the cell pellet was suspended 
into 1 mL of sterile deionised water and transferred to a sterile 1.5 mL Eppendorf tube. 
Cells were pelleted by centrifuging at 13500 rpm (table top centrifuge) for 30 seconds 
and the supernatant was decanted off. The pellet was suspended into the remaining 
liquid by pipetting. A volume of 0.2 mL of 2 % Triton X-100, 1% SDS, 100 mM NaCl, 10 
mM Tris-HCL (pH 8), 1 mM Na2 EDTA was added to the cell suspension. 0.2 mL of 
phenol:chloroform:isoamyl alcohol in the ratios of 25:24:1 was added with 0,3 g of acid 
washed glass beads. The sample was then vortexed in a Precellys 24 (Bertin technol-
ogies) vortexer in 30 second pulses for total of 4 minutes. The sample was kept on ice 
between pulses. After vortexing 0.2 mL of TE (pH 8) was added and then centrifuged 
for 5 minutes at 13500 rpm. The upper water phase from the tube was transferred to a 
new tube and 0.2 ml of phenol:chloroform:isoamyl alcohol (25:24:1) was added. The 
sample was inverted a few times and then centrifuged for 5 minutes at 13500 rpm. The 
upper water phase was transferred to a new tube and 1 mL of ice gold 94 % ethanol 
was added and the mixture was mixed by inverting the tube. After mixing the sample 
was centrifuged for 20 minutes at 14000 rpm at 4 °C. The supernatant was removed 
with a pipette and the DNA was suspended into 0.4 mL of TE (pH 8). 1.5 µL of 20 
mg/ml RNase was added and the mixture was incubated for 5 minutes at 37 °C. 1 mL 
of ice cold 94 % ethanol and 4 µL of 10 M ammonium acetate were added and mixed 
by inverting the sample. After mixing the sample was centrifuged for 20 minutes at 
14000 rpm at 4 °C and the supernatant was removed by pipetting. The DNA pellet was 
washed with 0.3 mL of 70 % ethanol and centrifuged for 20 minutes at 13500 rpm. The 
ethanol was decanted of and the pellet was left to dry at room temperature for 4 hours. 
The pellet was suspended into 50 µL of TE (pH 8) and stored at -20 °C 
2.2 PCR and agarose gel electrophoresis 
KAPA Hifi DNA polymerase (Kapa Biosystems) was used to amplify the genes hasD, 
hasC and hasE from the gDNA of Pichia pastoris strain GS115 (Invitrogen), and genes 
xhasA2 and xhasB were isolated from plasmids constructed by MSc. Pandeeswari 
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Jeeva. KAPA HiFi PCR primers (Integrated DNA Technologies) used in this thesis can 
be found in Table 1. 
 Kapa HiFi PCR primers, their products sizes, primer directions and restriction 
sites 
Gene Template 
PCR 
product 
size 
Primer Sequence 
Primer direc-
tion and re-
striction site 
TM °C 
hasC 
gDNA 
P. pastoris 
GS115 
1512bp 
oSBP-
072 
ACTACTCGA-
GAAAAATGTCTGCTTA
CCAGTCC 
Forward  XhoI 60.8 
oSBP-
073 
ACTATCTAGATTAG-
TGCTCCAAGA-
TAGTCAAGTTTC 
Reverse XbaI 58.5 
hasD 
gDNA 
P. pastoris 
GS115 
1433bp 
oSBP-
074 
ACTACTCGA-
GAAAAATGTCTTT-
GGAGCAGTAC 
Forward  XhoI 59.6 
oSBP-
075 
ACTATCTAGATTAGA-
TAACGTCAC-
CGTTCTTGAA 
Reverse XbaI 58.2 
hasE 
gDNA 
P. pastoris 
GS115 
1683bp 
oSBP-
076 
ACTACTCGA-
GAAAAATGCCATCTTT
GTTG 
Forward  XhoI 57.6 
oSBP-
077 
ACTATCTA-
GATTAGGCCCAA-
GCCTTGAAC 
Reverse XbaI 59.5 
xhasA2 Plasmid ~1700bp 
oSBP-
078 
ACTACTCGA-
GAAAAATGCAC-
TGCGAGAGGTTCATC 
Forward  XhoI 63.5 
oSBP-
079 
ACTATCTAGAT-
TATGCTAG-
CACAAGGTCATGC 
Reverse XbaI 59.3 
xhasB Plasmid ~1500bp 
oSBP-
080 
ACTACTCGA-
GAAAAATGTTTCAGAT
CAAAAAAATATGTTGC 
Forward  XhoI 60.5 
oSBP-
081 
ACTATCTAGAT-
TA-
TACCCTCTGCTTTTTAT
GGGG 
Reverse XbaI 60.8 
PCR programmes and reaction mixes were generated according to manufacturer’s 
instructions (Kapa Biosystems, 2016). To optimize the PCR and reduce nonspecific 
PCR products the annealing temperature was varied by ± 2 °C. An example of a KAPA 
Hifi PCR programme can be found in Table 2.  
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 Example of a PCR programme for KAPA HiFi 2x ready mix 
Step °C Time 
1 Initial denaturation 95 3 min 
2 Denaturation 98 20 sec 
3 Annealing 60 15 sec 
4 Extension 72 30-60 sec/kb 
5 Cycling go to step 2 30 x 
6 Final extension 72 60 sec/kb 
7 Storage temperature 4 forever 
All agarose gel electrophoreses were done on a 1% gel with added ethidium bromide 
and the voltage used was 150 V. The volume of 5X loading dye used was 20% of the 
total volume loaded into each well and the standard used was GeneRuler 1kb (Thermo 
Fisher). The amplified genes were purified from the agarose gel with the QIAquick Gel 
Extraction kit (QIAGEN).  
2.3 Restriction enzyme digestions and T4 ligase ligations 
Restriction enzyme digestions with Xba-I and Xho-I were done according to manufac-
turer’s instructions (Thermo Fisher, 2012) with one exception, the incubation times for 
gel extracted and purified genes was 1 hour at 37 °C and 6 hours for pGAPZB at 37 °C. 
The purification of the has gene restriction products were done with the QIAquick PCR 
Purification kit (QIAGEN) or and the restriction product of the pGAPZB was purified 
from an agarose gel using the QIAquick Gel Extraction kit (QIAGEN). Ligations of the 
purified genes to the linearized pGAPZB were done with T4 ligase (New England Bi-
olabs). Molar ratio of vector to insert used was 1:3 and the ligations were incubated 
overnight at 4 °C.   
2.4 E.coli electroporation  
E.coli electroporation was done with TOP10 electrocompetent E.coli. The cells were 
thawed on ice for ~15 minutes and 2 µL of the ligated construct (for example pGAPZB-
xhasA2) was added to 50 µL of competent cells. The mixture was gently mixed with a 
pipette and then moved to a cold 0.2 cm electroporation cuvette. Parameters used for 
the pulse were as follows: 
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 Voltage 2.5kV 
 Capacitor 25µF 
 Resistor 200Ω 
After the 2.5kV pulse was given with Bio-Rad GenePulser II, 750 µL of low salt LB was 
added immediately after to the cuvette. The mixture was mixed by pipetting gently and 
then transferred to a sterile 15 mL falcon tube. The tubes were incubated at 37 °C, 230 
rpm for 30 - 60 minutes, then 200 µL and 20 µL of the transformed cells were plated on 
separate low salt LB plates containing 25 µg/ml Zeocin. Plates were incubated over 
night at 37 °C or at 24 °C over the weekend. 
2.5 E.coli colony PCR 
Transformed E.coli colonies were screened using E.coli colony PCR according to man-
ufacturer’s instructions (Thermo Fisher, DyNAzyme II) with three exceptions, the reac-
tion volume was scaled down to 30 µL, the initial denaturation time was increased to 3 
minutes (lysis of E.coli cells) and the template used was a pipette tip full of E.coli colo-
ny that was mashed to the bottom of a 96-well plate well and the amount of sterile wa-
ter was adjusted accordingly. The same pipette tip was used to make a streak on a 
fresh low salt LB plate containing 25 µg/mL zeocin and the plate was incubated at 37 
°C overnight. The primers used for E.coli colony PCR can be found in Table 3 
 E.coli colony PCR primers. 
Gene 
name Template 
PCR 
product 
size 
Primer Sequence TM °C 
xhasA2 xhasA2+pGAPZB 675bp 
oSBP 14 
foward GTACACAACCGAAGTAAGACTG 57.9 
oSBP 15 
reverse GGCACTACACCTTATCATTCAG 60.1 
xhasB xhasB+pGAPZB 825bp 
oSBP 17 
foward AGGCACGTATTAATGCTTGGA 63.2 
oSBP 19 
reverse TGGGTCATGCTTTCAGAAGG 65.1 
Volume of 7,5 µL of loading dye was added to the PCR products and the PCR products 
were loaded onto a 1% agarose gel and voltage of 150 V was applied for roughly 1 
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hour. Suitable candidates for plasmid purification were chosen according to the PCR 
product size and 2.5 mL of fresh low salt LB media containing 25 µg/mL zeocin was 
inoculated with the E.coli from the streaks. The E.coli were grown overnight at 37 °C. 
2.6 Restriction enzyme analysis of purified cloned plasmids 
The cloned plasmids chosen with E.coli colony PCR were purified using the GeneJET 
miniprep plasmid purification kit (Thermo Fisher) and restriction digested as follows. 
Into a 1.5 mL tube 5 µL of cold sterile water was added followed by 1.4 µL of 10X 
FastDigest buffer (Thermo Fisher) as well as 0.3 µL (2 U/µL) of both Xba-I and Xho-I 
(Thermo Fisher). The mixture was mixed by pipetting and briefly spun down with a ta-
ble top centrifuge. A volume of 7 µL of the purified cloned plasmid was added and the 
mixture was incubated for 1 hour at 37 °C. After the incubation 3.5 µL of loading dye 
was added and the mixture was loaded onto a 1% agarose gel. A voltage of 150 V was 
applied for roughly 1 hour. The correctly ligated plasmids were identified from the gel 
and sent for sequencing. 
2.7 Sequencing 
Successfully constructed plasmids were sent to Seqlab Sequence Laboratories GmbH 
(Germany). The primers used for sequencing can be found in Table 4. The sequencing 
solutions were done according to Seqlabs instructions (SEQLAB Sequence Laborato-
ries, 2013) 
 Sequence primers for pGAPZB xhas constructs 
Primer Sequence TM °C 
oSBP 
082 CTAGCAAGACCGGTCTTCTC 55.5 
oSBP 
083 GGTTTCTTCTGACCCAAAGAC 54.7 
After the confirmation that the constructs were successfully ligated and the insert was 
in the correct frame, the plasmids were linearized with Blg-II for transformation by elec-
troporation into Pichia pastoris.  
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2.8 Bgl-II linearization and Pichia pastoris electroporation 
Bgl-II linearization of the plasmid DNA was done according to manufacturer’s instruc-
tions (Thermo Fisher 2012). The amount of DNA digested was between 4 µg and 10 µg 
and the digestion time was 2 hours at 37 °C. The digestion products were purified with 
QIAquick PCR Purification kit (QIAGEN) and then ethanol precipitated with 1/10 vol-
ume of 3 M sodium acetate, 2.5 volumes of 96 % ethanol. The mixture was incubated 
at - 20 °C for 20 minutes and then centrifuged for 10 minutes at 14000 rpm at 4 °C. The 
supernatant was pipetted off and the pellet was washed with one volume of 70 % etha-
nol. After the addition of 70 % ethanol, the mix was centrifuged for 5 minutes at 14000 
rpm at 4 °C. The pelleted DNA was suspended in cold sterile water.  
The electrocompetent cells were made from a glycerol stock of P.pastoris strain GS115 
according to manufacturer’s instructions (Life Technologies Corporation, 2010, p17). 
The electroporation to P.pastoris, with the combinations of cloning vectors pGAPZB-
xhasA2, -xhasB as well as -xhasA2 and -xhasB, were done according to manufactur-
er’s instructions (Life Technologies Corporation, 2010, p17; Bio-Rad Laboratories, 
p10). Transformants were plated on YPDS plates containing 100 µg/ml Zeocin and 
grown at 30 °C for four days. 
2.9 Pichia pastoris colony PCR 
Transformed colonies were screened using colony PCR (DyNAzyme II). Streaks from 
the transformed colonies of Pichia pastoris were made on a fresh YPDS plates contain-
ing 100 µg/ml Zeocin and incubated overnight at 30 °C. These streaks were screened 
using the following protocol for the correct integration of the xhas genes into the GAP 
locus. Small amount of the yeast colony was suspended into 30 µL of Zymolyase (1 
mg/ml Zymolyase in 1 M sorbitol) in a 96 well plate well. The suspension was incubat-
ed for 1.5 hours at 37 °C and 5 µL was used as a template for DyNaZyme II PCR which 
was done according to manufacturer’s instructions (Thermo Fisher, DyNAzyme II). 
Primers used in the Pichia Pastoris colony PCR can be found in Table 5. 
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 Primers used for Pichia Pastoris colony PCR 
Gene 
name Template 
PCR 
prod-
uct 
size 
Primer Sequence TM °C 
xhasA2 pGAPZB+xhasA2 integrated 432bp 
oSBP 082 
forward 
CTAGCAAGAC-
CGGTCTTCTC 55.5 
oSBP 016 
reverse 
GCAC-
TTTCTCAGGTAG-
TCCTC 
59.5 
xhasB pGAPZB+xhasB integrated 392bp 
oSBP 082 
forward 
CTAGCAAGAC-
CGGTCTTCTC 55.5 
oSBP 018 
reverse 
GCTGATAAACAC-
TAAATCCGCT 61.4 
A volume of 12.5 µL of 5X loading dye was added to the PCR products and then load-
ed into a 1% agarose gel. A voltage of 150 V was applied for roughly 1½ – 2 hours. 
3 Results 
Kapa Hifi PCR  
Two specific PCR products were produced from the plasmids containing the xhasA2 
and xhasB genes and no specific products were produced from the gDNA of P.pastoris 
GS115. The annealing temperature was varied by ± 2 °C, and the template DNA con-
centration was varied from either ¼ or 1 (1 – 10 ng/µL) times the recommended 
amount. Neither the DNA concentration nor the varied annealing temperature, affected 
the PCR products that were amplified from the gDNA (figure 8). 
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 KapaHifi PCR products at an annealing temperature of 60 °C and a varying template 
concentration. 
No correct sized PCR products (~ 1.4 kb – 1.7 kb) were produced at any annealing 
temperature or template concentrations from the gDNA (Appendix 1). XhasA2 and 
xhasB PCR products were produced at an annealing temperature of 60 °C and the rec-
ommended template concentration (Figure 8). 
E.coli colony PCR 
E.coli colony PCR produced specific products only from transformants which had the 
pGAPZA-xhasA2 and pGAPZB-xhasA2 cloning vectors and no specific products were 
produced from the xhasB cloning vector even though the number of amplification 
cycles were increased from 30 to 35 and the annealing temperature was changed from 
50 °C to 55 °C. The Colony PCR produced specific products from the wrong pGAPZA-
xhasA2 cloning vector transformants (Appendix 2, Figure 2.1 A), Once the correct clon-
ing vector pGAPZB-xhasA2 was transformed into the E.coli, the correct PCR products 
were produced from the pGAPZB-xhasA2 transformants (Figure 9). 
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 E.coli colony PCR where pGAPZB xhasA2 transformants are producing correct sized 
PCR products (~ 700 bp). Annealing temperature 50 °C and amplification of 30 cycles 
No specific PCR products were produced from either of the cloning vectors pGAPZA-
xhasB or pGAPZB-xhasB (Appendix 2, Figures 2.1 B - D). The annealing temperature 
(50 - 55 °C) and the amplification cycles (30 - 35 cycles) were varied, but this approach 
did not produce any specific PCR products of the correct size (~ 800 bp). 
Restriction analysis of the cloning vectors 
Initial unsuccessful ligations with the Xba-I and Xho-I digested products were due to 
the wrong cloning vector pGAPZA used. Multiple troubleshooting efforts were made to 
deduce the problem with this ligation. The digestion time for the pGAPZA was in-
creased from 1 hour to 6 hours at 37 °C; this approach did not produce any correct 
transformants (Appendix 3, Figure 3.1). Ligation time was then increased from 1 hour 
at room temperature to overnight at 4°C with no significant improvement (Appendix 3, 
figure 3.2). After these results, the pGAPZA vector was changed to the pGAPZB vec-
tor. Once the pGAPZB vector was purified correctly and the concentration of the vector 
was high enough in the ligation mixture (~ 25 - 50 ng/µL), the ligation produced correct 
transformants (Figure 10). 
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 A) Restriction digestion analysis of the pGAPZB-xhasB plasmids. Most plasmids are 
digested to the correct product sizes of 1.5 kb and 2.9 kb. B) Restriction digestion analysis of 
the pGAPZB-xhasA2 plasmids. Most plasmids are digested to the correct product sizes of 
1.7 kb and 2.9 kb 
Four potential pGAPZB-xhasA2 and three potential pGAPZB-xhasB plasmids were 
sent for sequencing. All the plasmids were assembled correctly, and the sequenced 
plasmids matched that of the plasmids constructed in silico (Genious 8.1.9). The se-
quenced plasmids were then linearized for Pichia pastoris electroporation transfor-
mations. 
Pichia pastoris colony PCR 
Transformations done with Bsp-HI linearized vectors did not produce any correct trans-
formants (Appendix 4, figure 4.1) This is because Bsp-HI cuts in the insert as well as 
the GAP promotor so even though colonies can be seen on selective plates there is no 
integrated pGAPZB-xhasA2/B vector at the GAP locus. The digestion enzyme was 
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changed from Bsp-HI to Bgl-II to avoid digesting the xhasA2 insert into two pieces. Af-
ter the successful transformation of the linearized vector, there was one colony on the 
xhasA2 plates, one on xhasA2 and xhasB plates and a total of eight colonies on the 
xhasB plates. The colony PCR from these colonies produced the correct sized PCR 
products from all the colonies and the negative control. Since the negative control was 
producing PCR products even though it should not, two more colony PCR reactions 
were made with new templates (Figure 11).  
 
 A) Amplification cycles of 35 and 30 with new templates. B) Amplification cycles 35, 
with new templates. Negative controls producing the correct sized PCR product with both 
primer pairs. A = colonies transformed with the pGAPZB-xhasA2 vector. B = colonies trans-
formed with the pGAPZB-xhasB vector. AB = colonies transformed with both vectors. (a) = 
primers used to screen for the pGAPZB-xhasA2 vector. (b) = primers used to screen for the 
pGAPZB-xhasB vector. (ab) = both primer pairs. 
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In Figure 11 we can see that the negative controls are still producing PCR products of 
the correct size from the new templates. 
4 Discussion 
Due to the time constraint for the completion of this thesis, no correct constructs with 
the right combinations of xhasA2, xhasB, hasC, hasD, hasE, FPs and Spo20 were pro-
duced. Instead a handful of potential strains of Pichia pastoris with the xhasA2 and 
xhasB integrated to the GAP promoter locus were produced.  
KAPA HiFi PCR 
The reason why no specific products were produced from the gDNA of P.pastoris is 
probably due to primer design or the template gDNA being used. Non-specific primer 
binding seems to be the more probable explanation since for example; in figure B (Ap-
pendix 1) the primers for hasD are producing five different products instead of one.  
E.coli colony PCR 
One explanation for the correct size PCR products been produced from the pGAPZA 
transformants, could be that the insert DNA left in the ligation mix has also been trans-
formed into the E.coli (Appendix 2, Figure 2.1 A). When the cells lysate, the DNA is 
released and amplified with PCR producing the correct PCR products. In figure 2.1 A 
(Appendix 2) the PCR products (~700bp) from the correct pGAPZB-xhasA2 vector can 
be seen. The difference in the brightness and hence the amount of PCR product can 
also be seen. Therefore, the assumption that the PCR products been produced in Fig-
ure 2.1 A (Appendix 2) are from the insert DNA transformed into to the E.coli, could be 
an explanation for these results. The PCR products been produced in Figure 2.1 A 
(Appendix 2) could also be due to non-specific primer binding to genomic homologue 
with a similar sequence to the xhasA2 gene. Unfortunately, these results do not confirm 
these assumptions and sequencing of these unspecific PCR products would be needed 
to confirm them. 
The lack of correct PCR products been produced for either the wrong pGAPZA xhasB 
cloning vector or the correct pGAPZB xhasB cloning vector (Appendix 2) is most likely 
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due to primer design. This assumption is supported by the fact that the primers for 
xhasB are producing PCR products of the wrong size as can be seen in Figure 2.1 D 
(appendix 2). 
Vector construction 
The results shown in the Appendix 3 are due to an unfortunate mistake, trying to insert 
the genes xhasA2 and xhasB to the cloning vector pGAPZA. The pGAPZA plasmid 
does not have the Xba-I restriction site so inserting the xhasA2 and xhasB genes di-
gested with both Xba-I and Xho-I is highly unlikely and the plasmid is more likely to 
ligate back into itself. After the discovery of the unfortunate mistake made with the 
wrong cloning vector pGAPZA, some problems with the ligations of the insert into the 
pGAPZB vector arose. Since the restriction digested pGAPZB vector was not purified 
on an agarose gel, the small fragment that was cleaved from the vector with Xba-I and 
Xho-I remained in the ligation mixture. Ligation of this fragment with, the cloning vector 
is more likely to happen than with the xhas genes; therefore, the chances of the insert 
ligating with the vector reduce significantly, producing vector only transformants. Once 
these mistakes were corrected, most plasmids analysed with restriction analysis pro-
duced that correct sized 2.9 kb vector backbone and either 1.7 kb fragment from the 
xhasA2 gene (Figure 10) or 1.5 kb fragment from the xhasB gene (Figure 10) 
Pichia pastoris colony PCR 
The probable explanation for the PCR products been produced from the negative con-
trols is a contamination of both the negative control templates. The template AB is pro-
ducing different sized products with different primer pairs which suggest that the strain 
might have both expression cassettes integrated into the GAP locus. The PCR prod-
ucts being produce from the xhasA2 and xhasB templates are roughly the correct size, 
so it’s reasonable to suggest that these expressions cassettes might have also been 
integrated. These results are somewhat questionable considering that the negative 
controls are also producing products, and to confirm the integration, another colony 
PCR could have been made with other primer pairs. The strains could also have been 
screened with qPCR to confirm the expression of the xhas genes. 
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5 Conclusions 
Due to the time constraints set for this thesis, all of its originals goals were not met and 
this is mostly due to the unfortunate mistake made with the pGAPZA cloning vector. 
The troubleshooting of the ligations into this vector took most of the time allotted; there-
fore, not enough time was left, to begin the production of the chimera proteins. The 
minor mistakes made in the restriction digestion of the cloning vector pGAPZB and the 
troubleshooting for this ligation also took more time than anticipated. In hindsight, a 
more detailed plan for the execution of the plasmid construction phase of this thesis 
would have probably yielded better results, but the initial goal would probably not have 
been met.  The possibility of successful integration of all the expression cassette com-
binations to P.pastoris does give some value to the SynBioPol project. If the integration 
has happened correctly, these strains can be used as a reference to compere the ex-
pression of these native proteins to the strain that expresses the chimera proteins. 
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Appendix 1 
 
  
KAPA HiFi PCR results 
 
Figure 1.1  A) Kapa Hifi PCR products at an annealing temperature of 58 °C. B) Kapa Hifi PCR 
products at an annealing temperature of 60 °C and varying template concentration. C) Kapa 
Hifi PCR products at an annealing temperature of 62 °C and varying template concentration. 
 
Appendix 2 
 
  
xhasA2 and xhasB colony PCR results 
 
Figure 2.1 Figure A shows the pGAPZA+xhasA2/B products. Figure B shows the column purified 
pGAPZB+xhasA/B vector with digestion time of 6 hours, ligation time of 3h and annealing 
temperature of 50°C. Figure C shows the gel purified pGAPZB+xhasB vector with digestion 
time of 6 hours, ligation time of overnight at 4°C and annealing temperature of 50°C.  In fig-
ure D the reaction conditions are exactly the same as in figure C but the annealing tempera-
ture has been raised from 50°C to 55°C 
Appendix 3 
 
  
Restriction analysis results for the pGAPZA-insert vectors 
 
Figure 3.1 Restriction analysis of pGAPZA-xhasA2/B transformants. pGAPZA was digested for 6 
hours at 37°C then ligated with inserts for 1 hour at RT. Only the linearized vector pGAPZA 
(2,9 kb) can be seen 
 
Figure 4.1 Restriction analysis of pGAPZA transformants. Ligation time of pGAPZA and inserts 
increased to overnight at 4°C 
 
Appendix 4 
 
  
Pichia pastoris colony PCR results with the Bgl-II linearized vectors 
 
Figure 5.1 A) Colony PCR results of the Bsp-HI linearized pGAPZB-xhasA2 plasmid. B) Colony 
PCR results of the Bsp-HI linearized pGAPZB-xhasB plasmid. No visible products can be 
seen except for the positive plasmid control (+). The negative control (-) of an untransformed 
GS115 colony did not produce any products. 
